Effect of Pegylated Interferon Plus Tenofovir Combination on Higher Hepatitis B Surface Antigen Loss in Treatment-naive Patients With Hepatitis B e Antigen -positive Chronic Hepatitis B: A Real-world Experience-Reference-Cited by-同舟云学术

Effect of Pegylated Interferon Plus Tenofovir Combination on Higher Hepatitis B Surface Antigen Loss in Treatment-naive Patients With Hepatitis B e Antigen -positive Chronic Hepatitis B: A Real-world Experience

Published:2021-03 Issue:3 Volume:43 Page:572-581.e3
ISSN:0149-2918
Container-title:Clinical Therapeutics
language:en
Short-container-title:Clinical Therapeutics

Author:

Hu Chengguang^ORCID,Song Yangda,Tang Cuirong,Li Meng,Liu Junwei,Liu Jia,Liao Minjun^ORCID,Zhou Fuyuan,Zhang Yong-Yuan^ORCID,Zhou Yuanping^ORCID

Funder

National Natural Science Foundation of China

Publisher

Elsevier BV

Subject

Pharmacology (medical),Pharmacology

Reference26 articles.

1. Estimations of worldwide prevalence of chronic hepatitis B virus infection: a systematic review of data published between 1965 and 2013;Schweitzer;Lancet,2015

2. Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance;Terrault;Hepatology,2018

3. EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection;J Hepatol,2017

4. Asian-Pacific clinical practice guidelines on the management of hepatitis B: a 2015 update;Sarin;Hepatol Int,2016

5. HBsAg seroclearance further reduces hepatocellular carcinoma risk after complete viral suppression with nucleos(t)ide analogues;Yip;J Hepatol,2019

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Systematic review with network meta-analysis: sustained hepatitis B surface antigen clearance after pegylated interferon cessation;European Journal of Gastroenterology & Hepatology;2024-07-22

2. Editorial: Trajectory of soluble programmed cell death protein‐1 and ligand‐1 in HBV‐infected individuals treated with pegylated interferon—Implications for stopping rules and the HBV cure programme. Authors' reply;Alimentary Pharmacology & Therapeutics;2024-07-17

3. Hepatitis B cure: Current situation and prospects;World Journal of Hepatology;2024-06-27

4. Predictive models for functional cure in patients with CHB receiving PEG-IFN therapy based on HBsAg quantification through meta-analysis;Hepatology International;2024-06-24

5. Comprehensive approach to controlling chronic hepatitis B in China;Clinical and Molecular Hepatology;2024-04-01